Celgene Corporation has notified the Foreign-Trade Zones (FTZ) Board about its proposed manufacturing activities in Warren and Summit, New Jersey. The notification seeks permission for these locations to operate under FTZ 49 to produce cell therapy products, allowing Celgene to avoid customs duties on certain foreign materials used in products destined for export. The company may also reduce or defer duties on foreign equipment and scrap. Public comments are invited until April 6, 2021, and further details can be obtained by contacting the FTZ Board.
Simple Explanation
Celgene Corporation wants to make special medicine in New Jersey and is asking for permission to use a special area called a "foreign-trade zone" so they can save money on taxes for materials brought from other countries. People can tell the government what they think about this idea until April 6, 2021.